RxDoctor Payments Data

Mae Nekoba, APRN

Acute Care · Henderson, NVNPI 1265887962

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 35.6% of the total. Reporting peaked in 2024 at $5,380 and has fallen 60.3% since, to $2,134 in 2025. Among acute care clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,921in general payments, 2019–2025

Across 96 payments — averaging $82.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$2K
  • Curonix LLC$1K
  • Lundbeck LLC$441
  • AbbVie$317
  • Averitas Pharma Inc.$290
  • plus $557 from 5 others

What the payments were for

  • Travel & lodging$4,09152%
  • Food & beverage$3,74147%
  • Education$901%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,921 in reported general payments places this provider in the 95th percentile of 129 acute care providers in Nevada.

See all acute care providers in Nevada

Medicare billing

Part B allowed, 2024
$212,923
Medicare patients
280
Services billed
2,932

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl52$35,258
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen428$27,859
Xtampza ErOxycodone Myristate39$16,456
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen444$10,837
BelbucaBuprenorphine Hcl11$7,278
Oxycodone Hcl330$6,699
Lidocaine57$5,516
Diclofenac Sodium93$3,454
Gabapentin304$3,326
Morphine Sulfate ErMorphine Sulfate159$3,295
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$2,865
Fentanyl26$2,688
Pregabalin172$2,575
Cyclobenzaprine Hcl230$2,080
Tizanidine Hcl212$2,054

Paid to pharmacies, not to this prescriber.

Other acute care in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →